Excel Cardiac Devices Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 25-07-2024
- Paid Up Capital ₹ 3.48 M
as on 25-07-2024
- Company Age 19 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.73 Cr
as on 25-07-2024
- Revenue 9.21%
(FY 2023)
- Profit 16.61%
(FY 2023)
- Ebitda 11.65%
(FY 2023)
- Net Worth 19.04%
(FY 2023)
- Total Assets -2.52%
(FY 2023)
About Excel Cardiac Devices
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.48 M.
The company currently has active open charges totaling ₹3.73 Cr.
Sidhartha Dutta and Satya Dutta serve as directors at the Company.
- CIN/LLPIN
U51507WB2005PTC106034
- Company No.
106034
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
31 Oct 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Excel Cardiac Devices?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sidhartha Dutta  | Director | 01-Dec-2005 | Current |
| Satya Dutta | Director | 31-Oct-2005 | Current |
Financial Performance of Excel Cardiac Devices.
Excel Cardiac Devices Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 9.21% increase. The company also saw a substantial improvement in profitability, with a 16.61% increase in profit. The company's net worth Soared by an impressive increase of 19.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Excel Cardiac Devices?
In 2023, Excel Cardiac Devices had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Cement Research Corporation Pvt LtdActive 64 years 10 monthsSidhartha Dutta and Satya Dutta are mutual person
- Premier Cube Private LimitedActive 16 years 1 month
Sidhartha Dutta and Satya Dutta are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 14 Sep 2020 | ₹2.20 M | Open |
Others Creation Date: 18 Jun 2007 | ₹3.51 Cr | Open |
How Many Employees Work at Excel Cardiac Devices?
Excel Cardiac Devices has a workforce of 13 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Excel Cardiac Devices, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Excel Cardiac Devices's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
